Proteomic research in sarcomas - current status and future opportunities.

Burns, Jessica; Wilding, Christopher P; L Jones, Robin; H Huang, Paul

Burns, Jessica; Wilding, Christopher P; L Jones, Robin; H Huang, Paul.

Afiliação

Burns J; Division of Molecular Pathology, The Institute of Cancer Research, London, SW3 6JB, UK.
Wilding CP; Division of Molecular Pathology, The Institute of Cancer Research, London, SW3 6JB, UK.
L Jones R; Division of Clinical Studies, The Institute of Cancer Research, London SW3 6JB, UK; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
H Huang P; Division of Molecular Pathology, The Institute of Cancer Research, London, SW3 6JB, UK. Electronic address: paul.huang@icr.ac.uk.

Semin Cancer Biol ; 61: 56-70, 2020 04.

Article em En | MEDLINE | ID: mdl-31722230

Assuntos

Proteoma; Proteômica; Sarcoma/metabolismo; Animais; Antineoplásicos/farmacologia; Antineoplásicos/uso terapêutico; Biomarcadores; Descoberta de Drogas; Humanos; Terapia de Alvo Molecular; Proteômica/métodos; Sarcoma/diagnóstico; Sarcoma/tratamento farmacológico; Sarcoma/etiologia

Palavras-chave

Biomarkers; Drug Discovery; Proteomics; Sarcoma; Targeted Therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Proteoma / Proteômica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google